ArticleChronic diseases and translational medicine2026
Baseline Body Mass Index Category and Incident Treated Hypertension in Australian Men: A Linked Prospective Cohort Study Using PBS/MBS Data.
Article in Chronic diseases and translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Excess adiposity is a major modifiable risk factor for hypertension; however, the incremental prognostic value of body mass index (BMI) beyond standard predictors remains unclear. We examined the associations between baseline BMI category and incident treated hypertension, and assessed whether BMI improved risk prediction. Methods: Data were obtained from the Ten to Men longitudinal study (2013-2024) linked to Pharmaceutical Benefits Scheme (PBS) and Medicare Benefits Schedule (MBS) records. The cohort comprised 12,742 men aged ≥ 18 years without treated hypertension at baseline, followed for 133,038 person-years. Adjusted Cox proportional hazards models were fitted. Discrimination, calibration, decision curve analysis, E-values, and BMI × age interactions were evaluated using bootstrap 95% confidence intervals (CIs). Results: During follow-up, 1755 men were initiated on antihypertensive therapy (13.2 per 1000 person-years). The 10-year cumulative incidence increased across BMI categories: 7.5% (95% CI 6.6-8.3) in normal-weight men, 10.3% (8.8-11.8) in underweight men, 12.0% (11.1-12.9) in overweight men, and 20.5% (18.9-22.0) in obese men. Fully adjusted hazard ratios (HRs) versus normal weight were 1.43 (95% CI 1.16-1.77) for underweight, 1.42 (1.22-1.67) for overweight, and 1.88 (1.59-2.22) for obesity; multiple-imputation estimates were similar. The BMI × age interaction was significant ( Conclusion: BMI is independently associated with incident treated hypertension and provides a modest additional prognostic value beyond age, with obesity having the strongest relative effect in early midlife.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.